LUCD Stock Analysis: Buy, Sell, or Hold?
LUCD - Lucid Diagnostics Inc. Common Stock
$1.19
0.05 (4.39%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 30, 2026
Get Alerted When LUCD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called LUCD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LUCD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: LUCD shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: LUCD is currently trading at $1.19, which is considered slightly low relative to its 30-day fair value range of $1.10 to $1.21.
Technical Outlook: Technically, LUCD is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.63. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.79 (+232.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LUCD is in a strong downtrend. Immediate support is located at $1.05, while resistance sits at $1.63. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.79 (+232.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.10 -
$1.21
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 232.6% below Wall St target ($3.79)
Fair Price Analysis
30-Day Fair Range
$1.10 -
$1.21
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.05
Resistance Level
$1.63
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.76
Wall Street Target
$3.79
(+232.6%)
Revenue Growth (YoY)
3.3%
Last updated: January 31, 2026 7:33 AM ET
Data refreshes hourly during market hours. Next update: 8:33 AM
Data refreshes hourly during market hours. Next update: 8:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUCD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Dennis Matheis
BUY
100000 shares
2025-08-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
Advanced LUCD Option Strategies
Professional options setups generated by AI based on today's LUCD price and gamma walls.
